🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
This is a randomized, double-blind, placebo-parallel intervention clinical ...
Status
Unknown
Location
The Second Affiliated Hospital of Chongqing Medical University
Start Date
2022-05-01
Trial ID
NCT06127498
To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-06-03
Trial ID
NCT04373460
Treatments Being Tested
Between June 10t h and July 1st, a cross-sectional design study in an Argen...
Status
Completed
Location
Hospital de Niños Ricardo Gutierrez
Start Date
2020-12-02
Trial ID
NCT04673279
Treatments Being Tested
The investigators are conducting a national COVID-19 prevalence survey on a...
Status
Completed
Location
University of Ljubljana
Start Date
2020-04-20
Trial ID
NCT04376996
Treatments Being Tested
This study aims to investigate the pathophysiology of recurrent pericarditi...
Status
Unknown
Location
Saarland University
Start Date
2023-07-01
Trial ID
NCT05925790
Treatments Being Tested
Convalescent plasma has been shown to be safe and effective for treatment o...
Status
Completed
Location
Department of Infectious Disease, Falu Hospital
Start Date
2020-12-03
Trial ID
NCT04649879
Treatments Being Tested
As of 30/03/2020, 715600 people have been infected with COVID-19 worldwide ...
Status
Completed
Location
CHU Sud Amiens
Start Date
2020-04-11
Trial ID
NCT04350580
Treatments Being Tested
To assess the association between neonatal SARS-CoV-2 antibody level at del...
Status
Unknown
Location
Schneider Children's Medical Center
Start Date
2021-09-12
Trial ID
NCT05564884
Treatments Being Tested
Sotrovimab is a newly developed monoclonal antibody for the treatment of mi...
Status
Unknown
Location
Emirats Health Service
Start Date
2021-11-14
Trial ID
NCT05144178